Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease
Open Access
- 9 February 2021
- Vol. 10 (2), 356
- https://doi.org/10.3390/cells10020356
Abstract
Fabry disease (FD) is a lysosomal storage disorder (LSD) characterized by lysosomal accumulation of glycosphingolipids in a wide variety of cytotypes, including endothelial cells (ECs). FD patients experience a significantly reduced life expectancy compared to the general population; therefore, the association with a premature aging process would be plausible. To assess this hypothesis, miR-126-3p, a senescence-associated microRNA (SA-miRNAs), was considered as an aging biomarker. The levels of miR-126-3p contained in small extracellular vesicles (sEVs), with about 130 nm of diameter, were measured in FD patients and healthy subjects divided into age classes, in vitro, in human umbilical vein endothelial cells (HUVECs) “young” and undergoing replicative senescence, through a quantitative polymerase chain reaction (qPCR) approach. We confirmed that, in vivo, circulating miR-126 levels physiologically increase with age. In vitro, miR-126 augments in HUVECs underwent replicative senescence. We observed that FD patients are characterized by higher miR-126-3p levels in sEVs, compared to age-matched healthy subjects. We also explored, in vitro, the effect on ECs of glycosphingolipids that are typically accumulated in FD patients. We observed that FD storage substances induced in HUVECs premature senescence and increased of miR-126-3p levels. This study reinforces the hypothesis that FD may aggravate the normal aging process.This publication has 68 references indexed in Scilit:
- Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomesJournal of Extracellular Vesicles, 2013
- A New Definition of Aging?Frontiers in Genetics, 2012
- Fabry diseaseOrphanet Journal of Rare Diseases, 2010
- Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular ProtectionScience Signaling, 2009
- Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cellsMolecular Genetics and Metabolism, 2008
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and AngiogenesisDevelopmental Cell, 2008
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1Proceedings of the National Academy of Sciences of the United States of America, 2008
- Aging, Natural Death, and the Compression of MorbidityThe New England Journal of Medicine, 1980